| | | | | |
TONX TON Strategy Company Common Stock | A$5,2726 | -5,05 % | A$315,50M | A$321,27K | |
| A$24,1616 | -1,99 % | A$315,08M | A$85,66K | |
TMCI Treace Medical Concepts, Inc. Common Stock | A$4,7538 | -2,31 % | A$314,76M | A$850,63K | |
HLXC Helix Acquisition Corp. III Class A Ordinary Shares | A$14,3876 | +0,39 % | A$314,29M | A$360,39 | |
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP. | A$7,5444 | -2,89 % | A$314,26M | A$485,17K | |
NKSH National Bankshares Inc/VA | A$47,8325 | -2,72 % | A$314,26M | A$64,10K | |
ADAG Adagene Inc. American Depositary Shares | A$4,8029 | +1,03 % | A$314,09M | A$66,87K | |
HDSN Hudson Technologies Inc | A$7,3901 | -0,57 % | A$313,84M | A$482,96K | |
PEBK Peoples Bancorp of North Carol | A$57,6065 | -2,56 % | A$313,47M | A$33,42K | |
MFM MFS Municipal Income Trust Shares of Beneficial Interest | A$7,5304 | -0,56 % | A$313,04M | A$186,31K | |
KROS Keros Therapeutics, Inc. Common Stock | A$14,7101 | -0,57 % | A$312,23M | A$266,88K | |
RNA Atrium Therapeutics, Inc. Common Stock | A$17,0590 | -0,69 % | A$311,83M | A$210,43K | |
RNAC Cartesian Therapeutics, Inc. Common Stock | A$8,7504 | -2,65 % | A$310,66M | A$242,28K | |
HELP Cybin Inc. Common Stock | A$6,0439 | -5,27 % | A$310,65M | A$725,51K | |
VENU Venu Holding Corporation | A$4,9501 | -4,08 % | A$310,40M | A$812,61K | |
